Pooling individual participant data from randomized controlled trials: Exploring potential loss of information

Background Pooling individual participant data to enable pooled analyses is often complicated by diversity in variables across available datasets. Therefore, recoding original variables is often necessary to build a pooled dataset. We aimed to quantify how much information is lost in this process and to what extent this jeopardizes validity of analyses results. Methods Data were derived from a platform that was developed to pool data from three randomized controlled trials on the effect of treatment of cardiovascular risk factors on cognitive decline or dementia. We quantified loss of information using the R-squared of linear regression models with pooled variables as a function of their original variable(s). In case the R-squared was below 0.8, we additionally explored the potential impact of loss of information for future analyses. We did this second step by comparing whether the Beta coefficient of the predictor differed more than 10% when adding original or recoded variables as a confounder in a linear regression model. In a simulation we randomly sampled numbers, recoded those < = 1000 to 0 and those >1000 to 1 and varied the range of the continuous variable, the ratio of recoded zeroes to recoded ones, or both, and again extracted the R-squared from linear models to quantify information loss. Results The R-squared was below 0.8 for 8 out of 91 recoded variables. In 4 cases this had a substantial impact on the regression models, particularly when a continuous variable was recoded into a discrete variable. Our simulation showed that the least information is lost when the ratio of recoded zeroes to ones is 1:1. Conclusions Large, pooled datasets provide great opportunities, justifying the efforts for data harmonization. Still, caution is warranted when using recoded variables which variance is explained limitedly by their original variables as this may jeopardize the validity of study results.

[1]  M. G. Haviland,et al.  Grouping Continuous Data in Discrete Intervals: Information Loss and Recovery , 1987 .

[2]  Oliver Butters,et al.  DataSHIELD: taking the analysis to the data, not the data to the analysis , 2014, International journal of epidemiology.

[3]  David A. Freedman,et al.  Statistical Models: Theory and Practice: References , 2005 .

[4]  R W Francis,et al.  ViPAR: a software platform for the Virtual Pooling and Analysis of Research Data , 2016, International journal of epidemiology.

[5]  E. Richard,et al.  An IS Approach for Handling Missing Data in Collaborative Medical Research , 2016 .

[6]  Kohske Takahashi,et al.  Create Elegant Data Visualisations Using the Grammar of Graphics [R package ggplot2 version 3.3.2] , 2020 .

[7]  H. Soininen,et al.  Improving data sharing in research with context-free encoded missing data , 2017, PloS one.

[8]  S. Lehéricy,et al.  Effect of long-term omega 3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in elderly adults with memory complaints (MAPT): a randomised, placebo-controlled trial , 2017, The Lancet Neurology.

[9]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[10]  P. Lee,et al.  Is a Cutoff of 10% Appropriate for the Change-in-Estimate Criterion of Confounder Identification? , 2013, Journal of epidemiology.

[11]  Parminder Raina,et al.  Maelstrom Research guidelines for rigorous retrospective data harmonization , 2016, International journal of epidemiology.

[12]  Edo Richard,et al.  Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial , 2016, The Lancet.

[13]  Lars Bäckman,et al.  A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial , 2015, The Lancet.

[14]  M. Tighiouart,et al.  Comparison between continuous and discrete doses for model based designs in cancer dose finding , 2019, PloS one.